Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jardiance vs Trajenta in NODAT after Kidney Transplantation
NCT03642184Phase 4Terminated
- Sponsor
- Renji Hospital
- Start
- Jul 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in post-transplant diabetes mellitus (PTDM), sponsored by Renji Hospital. Started Jul 2018; status: terminated.
02
Drugs
empagliflozin
03
Conditions
post-transplant diabetes mellitus (PTDM)
Beyond the preview
Go deeper on NCT03642184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03642184.